172 related articles for article (PubMed ID: 22412972)
1. Lung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instability.
Thu KL; Vucic EA; Chari R; Zhang W; Lockwood WW; English JC; Fu R; Wang P; Feng Z; MacAulay CE; Gazdar AF; Lam S; Lam WL
PLoS One; 2012; 7(3):e33003. PubMed ID: 22412972
[TBL] [Abstract][Full Text] [Related]
2. Frequency of driver mutations in lung adenocarcinoma from female never-smokers varies with histologic subtypes and age at diagnosis.
Zhang Y; Sun Y; Pan Y; Li C; Shen L; Li Y; Luo X; Ye T; Wang R; Hu H; Li H; Wang L; Pao W; Chen H
Clin Cancer Res; 2012 Apr; 18(7):1947-53. PubMed ID: 22317764
[TBL] [Abstract][Full Text] [Related]
3. Genomic and transcriptional alterations in lung adenocarcinoma in relation to EGFR and KRAS mutation status.
Planck M; Edlund K; Botling J; Micke P; Isaksson S; Staaf J
PLoS One; 2013; 8(10):e78614. PubMed ID: 24205279
[TBL] [Abstract][Full Text] [Related]
4. Genomic aberrations in lung adenocarcinoma in never smokers.
Job B; Bernheim A; Beau-Faller M; Camilleri-Broët S; Girard P; Hofman P; Mazières J; Toujani S; Lacroix L; Laffaire J; Dessen P; Fouret P;
PLoS One; 2010 Dec; 5(12):e15145. PubMed ID: 21151896
[TBL] [Abstract][Full Text] [Related]
5. Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas.
Paik PK; Johnson ML; D'Angelo SP; Sima CS; Ang D; Dogan S; Miller VA; Ladanyi M; Kris MG; Riely GJ
Cancer; 2012 Dec; 118(23):5840-7. PubMed ID: 22605530
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of oncogenic driver mutations in lung adenocarcinomas from East Asian never smokers.
Li C; Fang R; Sun Y; Han X; Li F; Gao B; Iafrate AJ; Liu XY; Pao W; Chen H; Ji H
PLoS One; 2011; 6(11):e28204. PubMed ID: 22140546
[TBL] [Abstract][Full Text] [Related]
7. Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose.
Li H; Pan Y; Li Y; Li C; Wang R; Hu H; Zhang Y; Ye T; Wang L; Shen L; Sun Y; Chen H
Lung Cancer; 2013 Jan; 79(1):8-13. PubMed ID: 23098378
[TBL] [Abstract][Full Text] [Related]
8. Whole genome copy number analyses reveal a highly aberrant genome in TP53 mutant lung adenocarcinoma tumors.
Bjaanæs MM; Nilsen G; Halvorsen AR; Russnes HG; Solberg S; Jørgensen L; Brustugun OT; Lingjærde OC; Helland Å
BMC Cancer; 2021 Oct; 21(1):1089. PubMed ID: 34625038
[TBL] [Abstract][Full Text] [Related]
9. Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression.
Zhang X; Zhang S; Yang X; Yang J; Zhou Q; Yin L; An S; Lin J; Chen S; Xie Z; Zhu M; Zhang X; Wu YL
Mol Cancer; 2010 Jul; 9():188. PubMed ID: 20624322
[TBL] [Abstract][Full Text] [Related]
10. Serum carcinoembryonic antigen levels before initial treatment are associated with EGFR mutations and EML4- ALK fusion gene in lung adenocarcinoma patients.
Wang WT; Li Y; Ma J; Chen XB; Qin JJ
Asian Pac J Cancer Prev; 2014; 15(9):3927-32. PubMed ID: 24935562
[TBL] [Abstract][Full Text] [Related]
11. Lungs don't forget: Comparison of the KRAS and EGFR mutation profile and survival of collegiate smokers and never smokers with advanced lung cancers.
Varghese AM; Sima CS; Chaft JE; Johnson ML; Riely GJ; Ladanyi M; Kris MG
J Thorac Oncol; 2013 Jan; 8(1):123-5. PubMed ID: 23242442
[TBL] [Abstract][Full Text] [Related]
12. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity.
Yang Y; Yang Y; Zhou X; Song X; Liu M; He W; Wang H; Wu C; Fei K; Jiang G
Lung Cancer; 2015 Mar; 87(3):272-7. PubMed ID: 25582278
[TBL] [Abstract][Full Text] [Related]
13. Relation between smoking history and gene expression profiles in lung adenocarcinomas.
Staaf J; Jönsson G; Jönsson M; Karlsson A; Isaksson S; Salomonsson A; Pettersson HM; Soller M; Ewers SB; Johansson L; Jönsson P; Planck M
BMC Med Genomics; 2012 Jun; 5():22. PubMed ID: 22676229
[TBL] [Abstract][Full Text] [Related]
14. Lung cancers unrelated to smoking: characterized by single oncogene addiction?
Suda K; Tomizawa K; Yatabe Y; Mitsudomi T
Int J Clin Oncol; 2011 Aug; 16(4):294-305. PubMed ID: 21655907
[TBL] [Abstract][Full Text] [Related]
15. Genomic and transcriptional alterations in lung adenocarcinoma in relation to smoking history.
Karlsson A; Ringnér M; Lauss M; Botling J; Micke P; Planck M; Staaf J
Clin Cancer Res; 2014 Sep; 20(18):4912-24. PubMed ID: 25037737
[TBL] [Abstract][Full Text] [Related]
16. DNA mismatch repair deficiency in surgically resected lung adenocarcinoma: Microsatellite instability analysis using the Promega panel.
Takamochi K; Takahashi F; Suehara Y; Sato E; Kohsaka S; Hayashi T; Kitano S; Uneno T; Kojima S; Takeuchi K; Mano H; Suzuki K
Lung Cancer; 2017 Aug; 110():26-31. PubMed ID: 28676214
[TBL] [Abstract][Full Text] [Related]
17. Silenced expression of NFKBIA in lung adenocarcinoma patients with a never-smoking history.
Furukawa M; Soh J; Yamamoto H; Ichimura K; Shien K; Maki Y; Muraoka T; Tanaka N; Ueno T; Asano H; Tsukuda K; Toyooka S; Miyoshi S
Acta Med Okayama; 2013; 67(1):19-24. PubMed ID: 23439505
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.
Shaw AT; Yeap BY; Mino-Kenudson M; Digumarthy SR; Costa DB; Heist RS; Solomon B; Stubbs H; Admane S; McDermott U; Settleman J; Kobayashi S; Mark EJ; Rodig SJ; Chirieac LR; Kwak EL; Lynch TJ; Iafrate AJ
J Clin Oncol; 2009 Sep; 27(26):4247-53. PubMed ID: 19667264
[TBL] [Abstract][Full Text] [Related]
19. Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches.
Drilon A; Wang L; Arcila ME; Balasubramanian S; Greenbowe JR; Ross JS; Stephens P; Lipson D; Miller VA; Kris MG; Ladanyi M; Rizvi NA
Clin Cancer Res; 2015 Aug; 21(16):3631-9. PubMed ID: 25567908
[TBL] [Abstract][Full Text] [Related]
20. The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma.
Kim HR; Lim SM; Kim HJ; Hwang SK; Park JK; Shin E; Bae MK; Ou SH; Wang J; Jewell SS; Kang DR; Soo RA; Haack H; Kim JH; Shim HS; Cho BC
Ann Oncol; 2013 Sep; 24(9):2364-70. PubMed ID: 23788756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
